Furthermore, studies on cognitive deficits in non-vascular disease demonstrated that increased NOX2 and p47phox expression and activation was involved in cognitive impairment in traumatic brain injury (TBI) [116,117,118,119], various encephalopathies [120,121,122,123], and metabolic diseases [13,124,125]. This evidence concerns the gene NCF1 and Cognitive impairment.